Cancer: Recurrent and/or Metastatic Solid Tumours research hub

A Phase I Open-Label, Single-Arm, Dose-Escalation Clinical and Pharmacology Study of CCI-001 as Monotherapy and in Combination With Standard Chemotherapy in Patients With Recurrent and/or Metastatic Solid Tumours

This study is testing a new drug, CCI-001, for people with advanced cancer that has come back or spread. It aims to find a safe dose and see how well the body handles the drug, both alone and with standard chemotherapy for specific cancer types.